Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

P&U discloses new distamycin derivatives with antitumor/antiviral efficacy

Aug. 18, 1998

Patent issued for Techniclone's Vascular Targeting Agent technology

Aug. 18, 1998

Bromocriptine reduces prolactin levels in patients with androgen-independent prostate cancer

Aug. 18, 1998

Novel antiandrogens in early development at Yamanouchi

Aug. 17, 1998

New antitumor agents isolated by Sagami

Aug. 17, 1998

Phase II trial of MGI Pharma's anticancer drug has commenced

Aug. 17, 1998

Daiichi team identifies new antitumor taxanes

Aug. 14, 1998

Endorex and UW-Madison will codevelop antitumor compounds

Aug. 14, 1998

Antitumor platinum complexes synthesized at SS Pharmaceutical

Aug. 14, 1998

Sugen and Taiho will jointly develop angiogenesis inhibitors

Aug. 14, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
Japan endorses two iPSC drugs for approval under CEA pathway
BioWorld
Japan is backing conditional approvals of Amchepry (raguneprocel, Sumitomo Pharma Co. Ltd./Racthera Co. Ltd.) and Reheart (Cuorips Inc.), positioning them to...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...